News
Merck & Co., Inc. (NYSE: MRK) is one of the. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback